Catalyst Pharm Inc (CPRX)

$5.81 0.00 (0.00%)

16:00 EDT CPRX Stock Quote Delayed 30 Minutes

7 Penny Stocks That Wall Street Thinks Are Undervalued

By Mark Putrino, CMT Mar 11, 2021

These penny stocks have more than just a low price point. They have Wall Street analysts backing up those prices with high price targets.

7 Penny Stock Companies That Actually Make Money

Despite Legal Drama, Catalyst Pharmaceuticals Looks Oversold

Why Catalyst Pharmaceuticals Stock Is Feeling the ‘Bern’

More Articles

Volume:

Previous Close -

Market Cap 598.30M

PE Ratio 8.30

EPS 0.7

Volume (Avg. Vol.) 295

Day's Range 5.81 - 5.81

52-Week Range 2.88 - 6.60

Dividend & Yield N/A (N/A)

CPRX Stock Predictions, Articles, and Catalyst Pharm Inc News

From InvestorPlace
From the Web

9 Robinhood Stocks Flying Under the Radar

By Josh Enomoto, InvestorPlace Contributor Sep 14, 2020

Robinhood stocks have generated much attention this year, but here are some names that you may not have heard about.

4 Strong Buy Biotech Stocks With Upcoming FDA Decisions

By Harriet Lefton, Writer, TipRanks Oct 23, 2018

These biotech stocks have fast-approaching PDUFA dates. Biotechs can soar or plunge on FDA decisions. These four pharma stocks should soar.

26 Biotechnology Stocks to Sell Now

By Portfolio Grader Sep 19, 2016

The ratings of 26 Biotechnology stocks are down this week, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

23 Biotechnology Stocks to Sell Now

By Portfolio Grader Sep 12, 2016

The overall ratings of 23 Biotechnology stocks are down on Portfolio Grader this week. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

Stocks Celebrate GOP Win on Bipartisan Hopes

By Anthony Mirhaydari, InvestorPlace Market Strategist Nov 5, 2014

Now on the horizon: The ECB, payrolls and Friday's showdown between President Obama and congressional leaders.

5 Red-Hot Biotech Stocks to Buy

By Anthony Mirhaydari, InvestorPlace Market Strategist Oct 27, 2014

Investors have been chasing risk again, buying up biotech stocks. Here's our list of the best biotech stocks out there.

The Daily Biotech Pulse: Allogene Sinks On FDA Clinical Hold, Takeda Gets Adcom Backing, Quidel Reports Q3 COVID Revenues, IPOs

From Benzinga Oct 8, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 7) Alkermes plc (NASDAQ: ALKS)...

Catalyst Pharmaceuticals Stock Reaches Resistance Level, Looks Ready To Break Out

From Benzinga Oct 6, 2021

Catalyst Pharmaceuticals Inc. (NASDAQ:CPRX) shares are tra...

The Daily Biotech Pulse: Moderna Invests In Africa, Amgen Announces Neuroscience R&D Collaboration, Decision Day For Chemocentryx, Biophytis To Restate Results

From Benzinga Oct 7, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 6) Enanta Pharmaceuticals, Inc...

Why Are Catalyst Pharma Shares Trading Higher On Thursday?

From Benzinga Sep 30, 2021

Catalyst Pharmaceuticals Inc (NASDAQ: CPRX) has received a favorable decision from the 11th Circuit Court of Appeals in its appeal to overturn a District Court...

The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer's Sleep Disorder Drug Filing Accepted For Review, Voyager's Licensing Options Deal

From Benzinga Oct 6, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 5) Bicycle Therapeutics plc (...

5 Value Stocks To Watch In The Healthcare Sector

From Benzinga Sep 27, 2021

The Meaning Behind Value Stocks A value stock traditionally has a lower price when compared to stock prices of companies in the same industry. This indicates that the company may...